![]() |
Open for inclusion |
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 FusionCancer type: Multiple diagnosis, Solide tumores Phase: I/II Principal Investigator: Guren Tormod Country: NO Keywords: Norway, Oslo, solide tumores, Zenocutuzumab, MCLA-128, NRG1 Fusion Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02912949 |